Evidence map›Paper›PMID 19403758›Full record

ArticleJournal of clinical microbiology2009

Rapid real-time nucleic Acid sequence-based amplification-molecular beacon platform to detect fungal and bacterial bloodstream infections.

Yanan Zhao, Steven Park, Barry N Kreiswirth, Christine C Ginocchio, Raphaël Veyret, Ali Laayoun, Alain Troesch, David S Perlin

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 79 citations in OpenAlex.

  1. Complex In Silico RNA Design with MoiRNAiFold.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Washed Away; How Not to Lose Your RNA during Isolation.Journal of biomolecular techniques : JBT · 2017
    Article
  6. Article
  7. Molecular Diagnostic Testing for Aspergillus.Journal of clinical microbiology · 2016
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2012
    Review
  15. Use and evaluation of molecular diagnostics for pneumonia etiology studies.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2012
    Review
  16. Article
  17. Molecular beacons in diagnostics.F1000 medicine reports · 2012
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Yanan ZhaoPublic Health Research Institute, UMDNJ-New Jersey Medical School, Newark, NJ 07103, USA.
Steven Park
Barry N Kreiswirth
Christine C Ginocchio
Raphaël Veyret
Ali Laayoun
Alain Troesch
David S Perlin
Rutgers New Jersey Medical SchoolInstitut Mérieux (France) · FRbioMérieux (France) · FRNorthwell Health · US

Funding

Rapid and Expandable Nucleic Acid Platform to Detect Bloodstream InfectionsU01AI066561 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI PERLIN, DAVID S · 2005 to 2009
$3.5M
NIAID NIH HHS AI066561NIAID NIH HHS U01 AI066561
6 · The paper itself

Abstract

Bloodstream infections (BSIs) are a significant cause of morbidity and mortality. Successful patient outcomes are diminished by a failure to rapidly diagnose these infections and initiate appropriate therapy. A rapid and reliable diagnostic platform of high sensitivity is needed for the management of patients with BSIs. The combination of an RNA-dependent nucleic acid sequence-based amplification and molecular beacon (NASBA-MB) detection system in multiplex format was developed to rapidly detect medically important BSI organisms. Probes and primers representing pan-gram-negative, pan-gram-positive, pan-fungal, pan-Candida, and pan-Aspergillus organisms were established utilizing 16S and 28S rRNA targets for bacteria and fungi, respectively. Two multiplex panels were developed to rapidly discriminate bacterial or fungal infections at the subkingdom/genus level with a sensitivity of 1 to 50 genomes. A clinical study was performed to evaluate the accuracy of this platform by evaluating 570 clinical samples from a tertiary-care hospital group using blood bottle samples. The sensitivity, specificity, and Youden's index values for pan-gram-positive detection and pan-gram-negative detection were 99.7%, 100%, 0.997 and 98.6%, 95.9%, 0.945, respectively. The positive predictive values (PPV) and the negative predictive values (NPV) for these two probes were 100, 90.7, and 99.4, 99.4, respectively. Pan-fungal and pan-Candida probes showed 100% sensitivity, specificity, PPV, and NPV, and the pan-Aspergillus probe showed 100% NPV. Robust signals were observed for all probes in the multiplex panels, with signal detection in <15 min. The multiplex real-time NASBA-MB assay provides a valuable platform for the rapid and specific diagnosis of bloodstream pathogens, and reliable pathogen identification and characterization can be obtained in under 3 h.

Indexed as

BacteremiaBacteriaBloodDNA PrimersFungiHumansMycosesOligonucleotide ProbesPredictive Value of TestsRNA, BacterialRNA, FungalRNA, Ribosomal, 16SRNA, Ribosomal, 28SSelf-Sustained Sequence ReplicationSensitivity and SpecificityDNA PrimersOligonucleotide ProbesRNA, BacterialRNA, FungalRNA, Ribosomal, 16SRNA, Ribosomal, 28S

Identifiers

PMID19403758
PMCPMC2708467
OpenAlexW2150440292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.